Drug intelligence / Profile preview

Stonespy

Development stage
Unknown
Lead developer
Octave Life Sciences
Administration
Oral
01

Overview

Stonespy is an Ayurvedic proprietary herbal medicine developed and marketed by Octave Life Sciences. Formulated as both an oral syrup and a capsule, Stonespy is designed for urinary system protection. It is utilized to support kidney health, prevent the formation of kidney stones, and assist in the management of urinary tract infections (UTIs). As a traditional multi-herb formulation, it leverages natural botanical extracts to promote overall renal and urinary tract wellness.

Brand names
Stonespy
Other names
Stonespy CapsuleStonespy Syrup

Beyond the preview

Go deeper on Stonespy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stonespy.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call